A Japanese health ministry panel approved Thursday the administration of Pfizer Inc.'s coronavirus vaccine to children aged 5 to 11, making it the first in Japan to be available for the age group.

Around 7 million children will be eligible to receive the COVID-19 vaccine from March at the earliest once it is granted special approval by the Ministry of Health, Labor and Welfare.

==Kyodo

© Kyodo News International, Inc., source Newswire